| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 19.000 +15.79% on 03/14/24 | | 24.000 -8.33% on 03/28/24 | +3.000 (+15.79%) since 03/01/24 |
| 3-Month | 17.000 +29.41% on 02/01/24 | | 26.300 -16.35% on 01/05/24 | -4.000 (-15.38%) since 01/03/24 |
| 52-Week | 13.100 +67.94% on 11/02/23 | | 600.000 -96.33% on 04/06/23 | -528.000 (-96.00%) since 04/03/23 |
/PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), a leading European pharmaceutical firm specializing in plant-derived...
/PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), a European based bio-pharma company specializing in the development and supply...
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces...
Sydney, June 15, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
Sydney, April 27, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
Sydney, April 22, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
Sydney, April 15, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
| 3rd Resistance Point | 22.000 |
| 2nd Resistance Point | 22.000 |
| 1st Resistance Point | 22.000 |
| Last Price | 22.000 |
| 1st Support Level | 22.000 |
| 2nd Support Level | 22.000 |
| 3rd Support Level | 22.000 |
| 52-Week High | 600.000 |
| Fibonacci 61.8% | 375.804 |
| Fibonacci 50% | 306.550 |
| Fibonacci 38.2% | 237.296 |
| Last Price | 22.000 |
| 52-Week Low | 13.100 |